Clinical trials
Pediatric Obesity trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 6 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University | 4 |
| Children's Hospital of Fudan University | 3 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 3 |
| China Medical University, China | 2 |
| Children's Hospital of Soochow University | 1 |
| Guangzhou Sport University | 1 |
| Jing Xin | 1 |
| Nanjing Children's Hospital | 1 |
| Ningbo No. 1 Hospital | 1 |
| Shaoxing Maternity and Child Health Care Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pediatric Obesity | 20 |
| Obesity | 4 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Cardiovascular Diseases | 1 |
| Genetic Predisposition to Disease | 1 |
| Insulin Resistance | 1 |
| Metabolic Diseases | 1 |
| Metabolic Syndrome | 1 |
| Overweight | 1 |
| Puberty, Precocious | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.